Real World Experience of Bedaquiline-Based Anti-Tubercular Regime in Multi-Drug Resistant Tuberculosis.
BACKGROUND: Tuberculosis is an important public healthcare problem in our country. Drug-resistant Tuberculosis is like a smoldering fire that if not controlled will flare up to an uncontrolled inferno. The conventional therapy for multidrug-resistant TB is associated with multiple issues like prolo...
Saved in:
Main Authors: | Vikas Marwah, Robin Choudhary, I M Pandey, Sandeep Rana, Anmol Sharma, Srishti Tripathy, Virender Malik, Shrinath V, Jyothis MC, Tentu Ajay |
---|---|
Format: | Article |
Language: | English |
Published: |
University Library System, University of Pittsburgh
2025-01-01
|
Series: | International Journal of Medical Students |
Subjects: | |
Online Access: | http://ijms.info/IJMS/article/view/2826 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights on Bedaquiline, Delamanid, and Linezolid
by: Huda Ahmed, et al.
Published: (2024-12-01) -
Multidrug-resistant Mycobacterium abscessus infection in an anophthalmic socket treated with bedaquiline on a compassionate use basis: A case report
by: David Galindo-Rodríguez, et al.
Published: (2024-12-01) -
New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01) -
Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01) -
Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01)